price
IM
NASDAQ · IMRX
Immuneering Corporation
Healthcare · Biotechnology
$3.74
Up+$0.01 (+0.27%)
Updated Oct 22, 2026, 12:03 PM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 224.71M
- P/E ratio
- -3.59
- Dividend yield
- 0.00%
- 52-week range
- $3.38 – $6.89
- Volume
- 478.53K
- Avg. volume
- 1.88M
Price performance · IMRX
IMRX price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 21, 2026
IMRX closed at $3.74 after 21 trading sessions, down 14.61% for the selected period.
- Last close
- $3.74
- Period change
- -14.61%
- Period low
- $3.42
- Period high
- $4.38
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 21, 2026 | $3.73 | $3.80 | $3.6801 | $3.74 | 478.53K |
| Oct 20, 2026 | $3.70 | $3.841 | $3.67 | $3.73 | 926.84K |
| Oct 19, 2026 | $3.61 | $3.67 | $3.5601 | $3.66 | 427.11K |
| Oct 16, 2026 | $3.65 | $3.68 | $3.575 | $3.59 | 747.89K |
| Oct 15, 2026 | $3.42 | $3.71 | $3.38 | $3.64 | 934.29K |
| Oct 14, 2026 | $3.51 | $3.598 | $3.41 | $3.42 | 805.72K |
| Oct 13, 2026 | $3.86 | $3.86 | $3.545 | $3.56 | 741.06K |
| Oct 12, 2026 | $3.94 | $3.945 | $3.8139 | $3.86 | 529.79K |
| Oct 9, 2026 | $3.75 | $3.955 | $3.68 | $3.94 | 709.72K |
| Oct 8, 2026 | $3.83 | $3.83 | $3.60 | $3.74 | 1.92M |
| Oct 7, 2026 | $3.78 | $3.915 | $3.74 | $3.86 | 747.68K |
| Oct 6, 2026 | $4.06 | $4.09 | $3.81 | $3.83 | 898.44K |
| Oct 5, 2026 | $4.07 | $4.12 | $4.02 | $4.04 | 482.71K |
| Oct 2, 2026 | $4.10 | $4.145 | $4.02 | $4.07 | 588.94K |
| Oct 1, 2026 | $4.10 | $4.17 | $4.01 | $4.03 | 538.18K |
| Sep 30, 2026 | $4.16 | $4.23 | $4.09 | $4.095 | 596.82K |
| Sep 29, 2026 | $4.16 | $4.16 | $4.065 | $4.13 | 574.6K |
| Sep 28, 2026 | $4.25 | $4.25 | $4.125 | $4.16 | 598.65K |
| Sep 25, 2026 | $4.36 | $4.40 | $4.255 | $4.27 | 513.54K |
| Sep 24, 2026 | $4.36 | $4.3799 | $4.20 | $4.34 | 590.13K |
| Sep 23, 2026 | $4.62 | $4.65 | $4.355 | $4.38 | 552.69K |
Latest IMRX news
The latest Smart Investors Daily articles mentioning IMRX.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…

